ASHLYNN GUARNERI: Open Payments
NPI 1780382820 · GENEVA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 31 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $102 · 2025 $685
Food & beverage: $649Education: $36
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 4 | $130 |
| Edwards Lifesciences Corporation | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| PFIZER INC. | 4 | $65 |
| SCPHARMACEUTICALS INC. | 3 | $55 |
| Boston Scientific Corporation | 1 | $37 |
| Medtronic, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: Attruby, JARDIANCE, WAINUA, FUROSCIX, VYNDAQEL, WATCHMAN, REPATHA, LEQVIO.
Industry payments across NY — which companies pay providers there.
